J. Morganroth
· 13 obras en el catálogo
Obras
"Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents"
Interventions in the Acute Phase of Myocardial Infarction
Use and Approval of Antihypertensive Agents and Surrogate Endpoints for the Approval of Drugs Affecting Antiarrhythmic Heart Failure and Hypolipidemia
Cardiac Arrhythmias : New Therapeutic Drugs and Devices
Sudden Cardiac Death and Congestive Heart Failure : Diagnosis and Treatment
The Evaluation of New Antiarrhythmic Drugs
Use and Approval of Antihypertensive Agents and Surrogate Endpoints for the Approval of Drugs Affecting Antiarrhythmic Heart Failure and ... & Devices, October 31 - November 1, 1989
Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents
Silent Myocardial Ischemia
Evaluation of Beat Blocker and Calcium Antagonist Drugs
Evaluation of New Antiarrhythmic Drugs : Proceedings of the Symposium on How to Evaluate a New Antiarrhythmic Drug
Cardiac Arrhythmias
